Search

Your search keyword '"Schmidt, Amand F."' showing total 370 results

Search Constraints

Start Over You searched for: Author "Schmidt, Amand F." Remove constraint Author: "Schmidt, Amand F."
370 results on '"Schmidt, Amand F."'

Search Results

5. Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes

7. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study

8. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

10. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

13. The Median and the Mode as Robust Meta-Analysis Estimators in the Presence of Small-Study Effects and Outliers

14. Prioritising genetic findings for drug target identification and validation

15. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study

16. Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease

17. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics

22. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies

23. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

24. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

27. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data

29. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity

30. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

31. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

32. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

33. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity

34. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

37. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization

38. Penetrance and Prognosis of MYH7Variant-Associated Cardiomyopathies

39. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

40. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

47. Unravelling the Difference Between Men and Women in Post-CABG Survival

48. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings

49. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia

50. Impact of Selection Bias on Estimation of Subsequent Event Risk

Catalog

Books, media, physical & digital resources